Hit identification

Finding active hits for selected targets

To find promising hits we offer diverse screening platforms combined with chemoinformatics and medicinal chemistry supported by artificial intelligence.

  • A priori selection
    Selection of molecules based on publications, virtual screening and medicinal chemistry knowledge.
  • Fragment Screening
    The NovA-Frag library of 1000 fragments can be screened on different biophysical platforms such as NMR or native MS.
  • Covalent screening
    Native-MS screening using client or commercial covalent libraries.
  • DNA Encoded Libraries (NovA-DEL)
    Massive screening in parallel of customized general or focused libraries.

Want more information?

We are ready to support your projects

Novalix is changing the future of drug discovery with a fresh new look.

The new website is currently
under construction.

NovAliX